10 U.S. Pharmaceutical industry Statistics You Should Know About

The US pharmaceutical industry generates tremendous revenue and employing millions. US Pharma companies are global leaders with a focus on research and development. Increasingly, there’s a growing demand for personalized medicine and targeted therapies.

After 2020 — the year everything was turned upside down — key processes and best practices in the industry were never the same again.

In an attempt to keep track of this rapidly evolving field, we’ve prepared a list of current pharmaceutical industry statistics you’d do good to know about.

• Last year, the global pharmaceutical market was valued at approximately $1.6 trillion while the US market generated revenues of $574 billion (roughly one-third the size of the global market).

• By the end of 2025, the US market will be worth $660 billion. Among the various sub-markets, oncology drugs is anticipated to be the largest, with a projected market volume of US$111.5 billion.

• The worldwide pharma market is projected to reach around $3 trillion by 2034, reflecting a compound annual growth rate (CAGR) of approximately 6.15% from 2024 to 2034. ​The US market is expected to surpass $800 billion by 2030.

• North America accounts for more than 53% of global pharmaceutical sales.

• The top 5 largest pharmaceutical companies by market cap are Eli Lilly, Novo Nordisk, Johnson & Johnson, Merck, and AbbVie.

• Approximately 1.3 million people are employed in the pharmaceutical industry in the United States (U.S. Bureau of Labor Statistics).

• The biopharmaceutical industry employs approximately 5.5 million people worldwide, including those involved in the manufacturing of generic medicines.

• Over 69 novel active substances (NASs) were launched globally in 2023, underscoring the industry’s commitment to innovation. ​

• 72% of active pharmaceutical ingredients (APIs) are now manufactured outside of the US. This means the US doesn’t have direct control over its pharmaceutical supply chain.

• There are more than 32,000 generic drugs that are approved by the FDA.

Recent Trends

The growing market adoption of innovative and modern medicines is a key driver of the U.S. pharmaceutical market. As patients and healthcare providers become more aware of the effectiveness of new treatments, there is an increasing demand for cutting-edge therapies that offer better outcomes and fewer side effects. The uptake of biologics, gene therapies, and immunotherapies in oncology, autoimmune diseases, and other areas has been particularly notable.

Digital Health and AI: The industry is increasingly leveraging digital health technologies and artificial intelligence for preventive and primary care, particularly in managing chronic diseases like cardiovascular conditions. ​

3D Printing: Advances in 3D printing are revolutionizing pharmaceutical manufacturing, enabling precision drug production with controlled release profiles and personalized dosing. ​

These insights highlight the pharmaceutical industry’s significant role in global health and its ongoing evolution driven by innovation and technological advancements.

Chemtech deals in a range of FDA-approved, “Made in USA” pharmaceutical products such as soft gel trays and syringe and vial trays. Get in touch if you’d like to find out more!